by David Eyre | Aug 1, 2014 | UK, US & International
Biopiracy is the evil sibling of bioprospecting. Bioprospecting is the search for existing genetic resources and biological knowledge that can be applied more widely and in novel applications. This is an area of particular interest to the pharmaceutical industry...
by David Eyre | Apr 1, 2014 | Briefings, US & International
Therefore, applicants may wish to consider filing any available complete applications and national phase entry applications in New Zealand prior to 13 September 2014 in order to not only avoid the more stringent patentability requirements of the New Act but also to...
by David Eyre | Apr 1, 2014 | US & International
Selected points of interest are as follows: New regulations to streamline and clarify existing procedures. This is done through detailing e filing provisions, introducing the “division of trade mark applications” for partially refused applications,...
by David Eyre | Apr 1, 2014 | Briefings, EPO, UPC
Consequently, it has long been desired to have a European patent with unitary effect, that is, a patent application that is searched and examined by the EPO but which upon grant is automatically in force in all EU member states. Progress towards such a unitary patent...
by Juliette Boynton | Mar 1, 2014 | EPO, UPC
The new unitary patents will be granted using the existing European patent application procedure, with the proprietor being able to choose whether to have a unitary patent or a number of national patents on grant. The Unitary Patent System is not currently in force as...
by George Schlich | Jun 1, 2013 | EPO
As background, Prof. Dr. Brüstle has parallel European and German patents relating to neural precursor cells, derivable from cells obtained from human embryos (as well as other sources). The patents are notable in that they were initially objected to in both...
Recent Comments